60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.96 (-3.69%), Market cap $0.00B, 52-week low–high $0.47 ~ $5.20.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and comme
Financial statements, price targets, institutional (13F) holdings and related news for 60 Degrees Pharmaceuticals, Inc. Common Stock are updated in real time on BlackAll Trade.
60 Degrees Pharmaceuticals, Inc. Common Stock trades at $0.96 (-3.69%). Real-time quotes and charts are available on BlackAll Trade.
60 Degrees Pharmaceuticals, Inc. Common Stock has a market cap of about $0.00B.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the Unite